°øÁö»çÇ×

³»¿ëºÐ·ù Á¤±â¼¼¹Ì³ª
°Ô½ÃÀÚ PGRC ()
Á¦¸ñ [PGRC]±Ý¿ä Àú³ÎŬ·´ °øÁö(2016/05/27)
ÂüÁ¶URL  ÂüÁ¶URL Á¤º¸¾øÀ½.
ÂüÁ¶ÆÄÀÏ  ÆÄÀϾøÀ½
³»¿ë
¾à¹°À¯Àüü¿¬±¸¼¾ÅÍ¿¡¼­´Â ´ÙÀ½°ú °°Àº ³»¿ëÀ¸·Î ¼¼¹Ì³ª¸¦ °³ÃÖÇÕ´Ï´Ù.
°ü½É ÀÖ´Â ±³¼ö´Ô, ¿¬±¸¿ø ¿©·¯ºÐÀÇ Àû±ØÀûÀÎ Âü¿© ¹Ù¶ø´Ï´Ù.



1) Àú³ÎŬ·´ ¿¬Á¦
- Human UDP-Glucuronosyltransferase (UGT) 2B10: Validation of
Cotinine as a Selective Probe Substrate, Inhibition by UGT
Enzyme-Selective Inhibitors and Antidepressant and Antipsychotic
Drugs, and Structural Determinants of Enzyme Inhibition
-Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing

2) Àú³ÎŬ·´ ¿¬ÀÚ
- ±è¹ÎÁ¤ / ÀÓ¼öÁ¤ ±èÀº°æ
- ±è¿ì¿µ / Á¶¼±¾Æ ÃÖÇâ±â ½ÅÈ£Á¤


3) ÀÏ ½Ã : 2016³â 05 ¿ù 27 ÀÏ (±Ý) ¿ÀÈÄ 4½Ã ~ 5½Ã

4) Àå ¼Ò : Àǰú´ëÇÐ 805È£